| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Apr'15 | Apr'14 | Apr'13 |
|---|---|---|---|---|---|---|
Operating Activities: | ||||||
Net Income (Loss) Attributable to Parent | ||||||
-155,176 | -189,399 | -25,089 | -62,789 | 57,848 | 54,890 | 46,358 |
Non-cash items included in net income (loss): | ||||||
Impairment of Intangible Assets (Excluding Goodwill) | ||||||
139,295 | 0 | 0 | - | - | - | - |
Goodwill, Impairment Loss | ||||||
42,417 | 0 | 0 | 18,348 | 0 | 0 | - |
Amortization | ||||||
40,375 | 37,194 | 45,881 | 45,511 | 1,039 | 1,342 | - |
Depreciation and amortization | ||||||
- | - | - | - | - | - | 4,638 |
Stock-based compensation | ||||||
32,553 | 26,923 | 19,062 | 19,569 | 11,940 | 11,240 | 11,683 |
Depreciation | ||||||
30,317 | 32,746 | 37,054 | 39,852 | 5,768 | 4,289 | - |
Deferred tax benefit | ||||||
-29,406 | -4,311 | 56 | - | - | - | - |
Remeasurement of contingent consideration to fair value | ||||||
-26,277 | -95,050 | -9,272 | -26,711 | 9,400 | -5,201 | 22,421 |
Amortization of operating lease assets | ||||||
12,297 | 0 | 0 | - | - | - | - |
Impairment of cost-method investments | ||||||
- | - | - | - | 0 | 0 | 4,059 |
Deferred license revenue amortization | ||||||
- | - | - | - | - | - | 1,494 |
Impairment of intangible assets | ||||||
- | - | - | - | - | - | 0 |
Impairment of property, plant and equipment | ||||||
-3,222 | -567 | -5,979 | -5,971 | 0 | 0 | 0 |
Amortization of income taxes payable on inter-company transfers of property | ||||||
2,575 | 13,370 | 31,784 | 25,952 | 0 | 0 | - |
Losses from equity method investments | ||||||
0 | -1,855 | -21,606 | -22,612 | 0 | 0 | 0 |
Gain on warrants' liability | ||||||
- | - | - | - | - | - | 1,326 |
Gain on acquisitions | ||||||
0 | 11,484 | 39,428 | 0 | 0 | - | - |
Impairment of discontinued operations | ||||||
0 | 0 | 93,574 | 0 | 0 | - | - |
Other than Temporary Impairment Losses, Investments | ||||||
0 | 0 | 8,565 | 0 | - | - | - |
Other | ||||||
-5,412 | -2,791 | -5,240 | -10,217 | -14 | 1,334 | 0 |
Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | ||||||
5,321 | -21,181 | 48,934 | 16,448 | 2,654 | 10,656 | 10,185 |
Inventories, net | ||||||
10,608 | 10,647 | -7,187 | -26,703 | 7,113 | -254 | 3,396 |
Other current and non-current assets | ||||||
2,103 | 12,989 | 6,180 | 32,686 | 2,112 | 2,716 | 405 |
Accounts payable and accrued current and non-current liabilities | ||||||
-31,830 | 4,526 | 7,522 | 1,645 | 5,546 | 2,088 | 6,565 |
Taxes payable | ||||||
-8,442 | 2,651 | -48,711 | - | - | - | - |
Litigation provision liability, net | ||||||
-123,695 | 294,061 | 0 | 0 | - | - | - |
Unrealized (gain) loss in foreign currency transactions | ||||||
- | - | - | - | - | - | -136 |
Restructuring reserve | ||||||
-6,747 | 6,504 | -14,557 | 12,405 | 0 | 0 | - |
Net cash (used in) provided by operating activities | ||||||
-91,142 | 120,489 | 91,339 | 90,151 | 79,676 | 54,196 | 79,054 |
Investing Activities: | ||||||
Investing Activities: | ||||||
Purchases of property, plant and equipment | ||||||
24,691 | 37,188 | 32,933 | 38,362 | 6,687 | 15,222 | 9,705 |
Acquisitions, net of cash acquired | ||||||
10,750 | 279,691 | 14,194 | 0 | 0 | - | - |
Purchases of intangible assets | ||||||
3,289 | 809 | 1,174 | - | - | 3,839 | 4,600 |
Purchase of investment | ||||||
2,500 | 3,770 | 6,255 | 8,026 | - | - | - |
Proceeds from asset sales | ||||||
1,261 | 14,220 | 5,935 | 1,145 | 0 | 0 | 0 |
Proceeds from the sale of CRM business franchise, net of cash disposed | ||||||
0 | 186,682 | 0 | 0 | - | - | - |
Proceeds from sale of investment | ||||||
0 | 0 | 3,192 | 0 | - | - | - |
Proceeds from sale of cost-method investment | ||||||
- | - | - | - | 0 | - | - |
Purchases of cost and equity method investments | ||||||
- | - | - | - | 1,182 | 5,356 | 6,588 |
Loans to investees | ||||||
0 | 0 | 7,426 | 6,270 | 0 | - | - |
Restricted cash | ||||||
- | - | - | - | - | - | 100 |
Purchases of short-term investments | ||||||
- | - | - | 7,054 | 31,985 | 39,985 | 15,000 |
Maturities of short-term investments | ||||||
- | - | - | 14,051 | 30,089 | 29,990 | 0 |
Other | ||||||
1,321 | 0 | 0 | - | - | - | - |
Cash obtained in the Merger | ||||||
- | - | - | - | 0 | 0 | 0 |
Net cash used in investing activities | ||||||
-41,290 | -120,556 | -52,855 | -44,516 | -9,765 | -34,412 | -35,993 |
Loans to equity method investments | ||||||
- | - | - | - | - | 0 | - |
Financing Activities: | ||||||
Financing Activities: | ||||||
Proceeds from long-term debt obligations | ||||||
197,160 | 103,570 | 2,048 | 7,231 | 0 | 0 | - |
Proceeds from exercise of stock options | ||||||
372 | 4,178 | 4,973 | 8,332 | 3,184 | 9,737 | 9,743 |
Proceeds from short term borrowings (maturities greater than 90 days) | ||||||
0 | 240,000 | 20,000 | 0 | 0 | - | 0 |
Repayment of long-term debt obligations | ||||||
24,210 | 23,827 | 22,755 | 21,109 | 0 | 0 | 0 |
Repayment of trade receivable advances | ||||||
- | - | - | 23,779 | 0 | 0 | - |
Payment of contingent consideration | ||||||
18,955 | 651 | 1,097 | - | - | - | - |
Shares repurchased from employees for minimum tax withholding | ||||||
7,064 | 11,611 | 4,083 | 272 | - | - | - |
Change in short-term borrowing, net | ||||||
-1,188 | -30,745 | 12,396 | 33,708 | 0 | 0 | - |
Proceeds from share issuances under ESPP | ||||||
4,468 | 0 | 0 | - | - | - | - |
Debt issuance costs | ||||||
3,795 | 0 | 0 | - | - | - | - |
Repayment of short-term borrowing (maturities greater than 90 days) | ||||||
0 | 260,000 | 0 | 0 | - | - | 0 |
Share repurchases under share repurchase program | ||||||
0 | 50,000 | 0 | 54,487 | 55,015 | 72,359 | 33,009 |
Payment of deferred consideration - acquisition of Caisson Interventional, LLC | ||||||
0 | 12,994 | 0 | 0 | - | - | - |
Other | ||||||
-207 | -268 | -188 | -247 | -3,575 | 0 | 0 |
Cash settlement of compensation-based stock units | ||||||
- | - | - | - | - | 1,323 | 0 |
Realized excess tax benefits - stock-based compensation | ||||||
- | - | - | - | - | 26,678 | 4,416 |
Net cash provided by financing activities | ||||||
146,581 | -42,348 | 11,294 | -118,039 | -48,256 | -37,267 | -18,850 |
Effect of exchange rate changes on cash and cash equivalents | ||||||
-216 | -3,996 | 4,048 | -420 | -767 | 73 | -157 |
Net increase in cash and cash equivalents | ||||||
13,933 | -46,411 | 53,826 | -72,824 | 20,888 | -17,410 | 24,054 |
Supplementary Disclosures of Cash Flow Information: | ||||||
Cash paid for interest | ||||||
15,828 | 9,278 | 7,510 | 7,371 | 1 | 4 | 96 |
Cash paid for income taxes | ||||||
2,011 | 26,393 | 38,974 | 47,808 | 15,577 | 4,296 | 3,518 |
Supplementary disclosure of non-cash operating transactions: | ||||||
Reclassification from common stock warrants to warrants' liability | ||||||
- | - | - | - | - | - | -3,650 |
Reclassification from common stock warrants to additional paid-in-capital | ||||||
- | - | - | - | - | - | -21,550 |
PP&E and intangible assets obtained in NeuroVista foreclosure | ||||||
- | - | - | - | - | - | 1,450 |
Settlement of the NeuroVista note | ||||||
- | - | - | - | - | - | -1,450 |
Acquisition financed by ordinary shares of LivaNova | ||||||
- | - | - | - | 0 | 0 | 0 |